Biogen Inc.
BIIB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2 | $3 | $2 | $2 |
| % Growth | -7.2% | 8.8% | -1% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | $2 | $2 | $2 | $2 |
| % Margin | 64.3% | 64.2% | 76.2% | 76.2% |
| R&D Expenses | $0 | $1 | $1 | $1 |
| G&A Expenses | $0 | $0 | $0 | $1 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | $1 | $1 | $1 | $1 |
| % Margin | 25% | 22.2% | 30.1% | 20.7% |
| Other Income/Exp. Net | -$0 | $0 | -$0 | -$0 |
| Pre-Tax Income | $1 | $1 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $1 | $0 | $0 |
| % Margin | 19% | 24% | 9.9% | 10.9% |
| EPS | 3.18 | 4.35 | 1.65 | 1.83 |
| % Growth | -26.9% | 163.6% | -9.8% | – |
| EPS Diluted | 3.17 | 4.35 | 1.64 | 1.83 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | $1 | $1 | $1 |
| % Margin | 33.7% | 42% | 35.6% | 28.2% |